Refresh

AARTI DRUGS LTD. - Intimation Of Approval Of Reclassification Of Promoter


Download
09 Aug 2022
Pursuant to the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is to inform that on August 8, 2022 the Company has received the approval letter from BSE Limited and National Stock Exchange of India Limited, for the application submitted for reclassification of Shareholding of Promoter/ Promoter Group to Public Category.

Source: BSE India

View all announcements for AARTI DRUGS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com